Naturally processed peptides from two disease-resistance-associated HLA-DR13 alleles show related sequence motifs and the effects of the dimorphism at position 86 of the HLA-DR beta chain.
about
Population genetics of malaria resistance in humansRedundancy in antigen-presenting function of the HLA-DR and -DQ molecules in the multiple sclerosis-associated HLA-DR2 haplotypeInfectious Diseases and Immunity: Special Reference to Major Histocompatibility ComplexClass II MHC self-antigen presentation in human B and T lymphocytesHLA class II gene frequencies in Crohn's disease: a population based analysis in GermanyMajor histocompatibility complex differentiation in Sacramento River chinook salmon.Electrostatic modifications of the human leukocyte antigen-DR P9 peptide-binding pocket and susceptibility to primary sclerosing cholangitisVariation in vaccine response in normal populations.Transport of misfolded endoplasmic reticulum proteins to the cell surface by MHC class II molecules.Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypesHuman leukocyte antigen class II association with spontaneous recovery from hepatitis B virus infection in Koreans: analysis at the haplotype levelComprehensive analysis of HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1 loci and squamous cell cervical cancer riskAutoantibodies to IgG/HLA class II complexes are associated with rheumatoid arthritis susceptibility.Cellular misfolded proteins rescued from degradation by MHC class II molecules are possible targets for autoimmune diseases.Role for HLA class II molecules in HIV-1 suppression and cellular immunity following antiretroviral treatmentChicken major histocompatibility complex class II molecules of the B haplotype present self and foreign peptides.HIV-1 variation diminishes CD4 T lymphocyte recognition.Definition of the peptide binding motif within DRB1*1401 restricted epitopes by peptide competition and structural modelingNeutral versus adaptive genetic variation in parasite resistance: importance of major histocompatibility complex supertypes in a free-ranging primate.Analysis of prognostic factors associated with longitudinally extensive transverse myelitis.Protective Effect of Human Leukocyte Antigen (HLA) Allele DRB1*13:02 on Age-Related Brain Gray Matter Volume Reduction in Healthy Women.HLA DR13 and HCV vertical infectionDifferential HLA Gene Expression in Measles Vaccine Seropositive and Seronegative Subjects: A Pilot StudyThe effects of human leukocyte antigen DRB1*13 and apolipoprotein E on age-related variability of synchronous neural interactions in healthy women
P2860
Q21032506-11F7D467-C898-4D48-AD76-15C1AA7270D0Q24652223-68F0F565-2101-4431-A812-6596C65FAB69Q27487586-5D0E08A9-DDBD-4738-AA04-90FD20D73B5DQ31047483-70EDFF6B-EADF-4584-97AF-5A1B181342FFQ34409570-116F66FB-81B2-4FC7-B59E-BAD896BBF35AQ34606448-BF011340-F910-4D07-B259-4E9E8AB69D74Q35083983-BFC3F816-B426-4601-8DAC-747C2E621B73Q35785237-30DA8BC3-091B-4240-944D-FFE0EB107E9EQ36685319-7EF510A1-EA6F-43B4-8A86-88424CC077F2Q36766285-48224D4D-8DB6-42E3-B638-9F05A264F820Q36966008-CCC68084-71F7-45E5-A230-CAFF5FFCAE15Q37143508-BBABB85C-6793-4EC3-A4F7-952BE4F2943DQ37640870-62E3684E-ECD7-4C27-B69D-5460F515A392Q38588610-3789194D-F677-4E85-B6AE-1C16C51B6B04Q39906623-C2F9509A-CFDD-438F-92FC-18EAFD6C348DQ40249605-BE8018BE-717F-4E53-8127-36258F1DFA72Q41811611-80F378AF-FDC6-4C9E-B307-45FEC1F464DFQ42684203-22E422E4-106A-41FD-9B84-1394AA640C12Q44429509-301D14E3-AF71-4EAC-B10C-94C87CDDBF24Q48349068-B76B7B97-A90D-4BE6-8197-D91A9EE03ED6Q49918651-7689CE34-E6E3-4685-908B-2911675C4A1BQ57005698-4A38A1D5-4FAF-4F49-A0FE-1657F7B12C40Q57157989-E76B4400-8F60-4648-AAB7-D8F31264DC95Q58732859-75424976-FC1D-4A29-A43F-9E744420169F
P2860
Naturally processed peptides from two disease-resistance-associated HLA-DR13 alleles show related sequence motifs and the effects of the dimorphism at position 86 of the HLA-DR beta chain.
description
1995 nî lūn-bûn
@nan
1995 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
name
Naturally processed peptides f ...... n 86 of the HLA-DR beta chain.
@ast
Naturally processed peptides f ...... n 86 of the HLA-DR beta chain.
@en
Naturally processed peptides f ...... n 86 of the HLA-DR beta chain.
@nl
type
label
Naturally processed peptides f ...... n 86 of the HLA-DR beta chain.
@ast
Naturally processed peptides f ...... n 86 of the HLA-DR beta chain.
@en
Naturally processed peptides f ...... n 86 of the HLA-DR beta chain.
@nl
prefLabel
Naturally processed peptides f ...... n 86 of the HLA-DR beta chain.
@ast
Naturally processed peptides f ...... n 86 of the HLA-DR beta chain.
@en
Naturally processed peptides f ...... n 86 of the HLA-DR beta chain.
@nl
P2093
P2860
P356
P1476
Naturally processed peptides f ...... n 86 of the HLA-DR beta chain.
@en
P2093
A C Willis
M P Davenport
P2860
P304
P356
10.1073/PNAS.92.14.6567
P407
P577
1995-07-01T00:00:00Z